

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.22182163 |
| 2 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.08235136 |
| 3 | hemoglobin metabolic process (GO:0020027) | 5.00638663 |
| 4 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.75338596 |
| 5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.63448592 |
| 6 | erythrocyte development (GO:0048821) | 4.52872050 |
| 7 | locomotory exploration behavior (GO:0035641) | 4.46517664 |
| 8 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.36881086 |
| 9 | sodium ion export (GO:0071436) | 4.33163569 |
| 10 | oxygen transport (GO:0015671) | 4.28729054 |
| 11 | cell communication by electrical coupling (GO:0010644) | 4.22335107 |
| 12 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.17289608 |
| 13 | gas transport (GO:0015669) | 4.09361876 |
| 14 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.03536992 |
| 15 | positive regulation of receptor recycling (GO:0001921) | 3.98674430 |
| 16 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.98346394 |
| 17 | regulation of synapse structural plasticity (GO:0051823) | 3.98263424 |
| 18 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.97205380 |
| 19 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.91199966 |
| 20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.87639022 |
| 21 | cardiac myofibril assembly (GO:0055003) | 3.85981082 |
| 22 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.84911870 |
| 23 | melanin biosynthetic process (GO:0042438) | 3.84399955 |
| 24 | plasma membrane repair (GO:0001778) | 3.84047449 |
| 25 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.83927980 |
| 26 | response to methylmercury (GO:0051597) | 3.83399524 |
| 27 | cell communication involved in cardiac conduction (GO:0086065) | 3.76072413 |
| 28 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.74511236 |
| 29 | cellular potassium ion homeostasis (GO:0030007) | 3.73637812 |
| 30 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.68761316 |
| 31 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.65984582 |
| 32 | potassium ion import (GO:0010107) | 3.63939932 |
| 33 | melanin metabolic process (GO:0006582) | 3.63641120 |
| 34 | myeloid cell development (GO:0061515) | 3.58422013 |
| 35 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.58053777 |
| 36 | activation of protein kinase A activity (GO:0034199) | 3.56518428 |
| 37 | cellular response to epinephrine stimulus (GO:0071872) | 3.51704616 |
| 38 | vocalization behavior (GO:0071625) | 3.51069964 |
| 39 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.50013858 |
| 40 | cardiac muscle contraction (GO:0060048) | 3.49886083 |
| 41 | macroautophagy (GO:0016236) | 3.49542906 |
| 42 | glutamate secretion (GO:0014047) | 3.46656787 |
| 43 | regulation of membrane repolarization (GO:0060306) | 3.45871989 |
| 44 | response to epinephrine (GO:0071871) | 3.40446130 |
| 45 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.39680503 |
| 46 | layer formation in cerebral cortex (GO:0021819) | 3.39265445 |
| 47 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.37642546 |
| 48 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.35130364 |
| 49 | synaptic vesicle exocytosis (GO:0016079) | 3.34864046 |
| 50 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.34807540 |
| 51 | iron ion import (GO:0097286) | 3.34130493 |
| 52 | sarcomere organization (GO:0045214) | 3.33464218 |
| 53 | heart process (GO:0003015) | 3.32677022 |
| 54 | heart contraction (GO:0060047) | 3.32677022 |
| 55 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.28837352 |
| 56 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.28795953 |
| 57 | myofibril assembly (GO:0030239) | 3.25328023 |
| 58 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.24609028 |
| 59 | tetrapyrrole biosynthetic process (GO:0033014) | 3.24409561 |
| 60 | positive regulation of fibroblast migration (GO:0010763) | 3.22153457 |
| 61 | proline transport (GO:0015824) | 3.21614926 |
| 62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.11287198 |
| 63 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.04163302 |
| 64 | actin filament capping (GO:0051693) | 3.03474525 |
| 65 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.03203073 |
| 66 | cortical actin cytoskeleton organization (GO:0030866) | 3.03129850 |
| 67 | neurotransmitter secretion (GO:0007269) | 3.03116146 |
| 68 | regulation of synaptic vesicle transport (GO:1902803) | 3.02711968 |
| 69 | regulation of ARF protein signal transduction (GO:0032012) | 3.01797478 |
| 70 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.01596212 |
| 71 | porphyrin-containing compound metabolic process (GO:0006778) | 3.01513373 |
| 72 | protein localization to endosome (GO:0036010) | 2.98236775 |
| 73 | negative regulation of potassium ion transport (GO:0043267) | 2.97511163 |
| 74 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.97036548 |
| 75 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.97036548 |
| 76 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.96133040 |
| 77 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.95479088 |
| 78 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.95170006 |
| 79 | exploration behavior (GO:0035640) | 2.93649506 |
| 80 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.92947465 |
| 81 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.92448723 |
| 82 | protein targeting to plasma membrane (GO:0072661) | 2.89268947 |
| 83 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.88796095 |
| 84 | regulation of receptor recycling (GO:0001919) | 2.85251414 |
| 85 | establishment of nucleus localization (GO:0040023) | 2.84110227 |
| 86 | striatum development (GO:0021756) | 2.83710637 |
| 87 | neuromuscular process controlling balance (GO:0050885) | 2.82732736 |
| 88 | regulation of cell communication by electrical coupling (GO:0010649) | 2.82510442 |
| 89 | membrane repolarization (GO:0086009) | 2.82029100 |
| 90 | membrane depolarization during action potential (GO:0086010) | 2.81201737 |
| 91 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.79155189 |
| 92 | regulation of response to osmotic stress (GO:0047484) | 2.78354355 |
| 93 | glycine transport (GO:0015816) | 2.77733463 |
| 94 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.77546634 |
| 95 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.76695879 |
| 96 | regulation of actin filament-based movement (GO:1903115) | 2.76368356 |
| 97 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.75711690 |
| 98 | negative regulation of anoikis (GO:2000811) | 2.73769190 |
| 99 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.72835715 |
| 100 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.72635274 |
| 101 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.72590649 |
| 102 | response to nerve growth factor (GO:1990089) | 2.72590649 |
| 103 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.72538620 |
| 104 | cardiac conduction (GO:0061337) | 2.72118920 |
| 105 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.71566496 |
| 106 | regulation of platelet aggregation (GO:0090330) | 2.71329196 |
| 107 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.70834405 |
| 108 | cell migration involved in heart development (GO:0060973) | 2.70597970 |
| 109 | protein localization to synapse (GO:0035418) | 2.69664060 |
| 110 | cellular sodium ion homeostasis (GO:0006883) | 2.69512952 |
| 111 | positive regulation of sodium ion transport (GO:0010765) | 2.68568719 |
| 112 | extracellular fibril organization (GO:0043206) | 2.68211509 |
| 113 | striated muscle contraction (GO:0006941) | 2.68167972 |
| 114 | secondary metabolite biosynthetic process (GO:0044550) | 2.68165924 |
| 115 | potassium ion homeostasis (GO:0055075) | 2.67887314 |
| 116 | cardiac muscle hypertrophy (GO:0003300) | 2.67300729 |
| 117 | long-term memory (GO:0007616) | 2.66888937 |
| 118 | positive regulation of macroautophagy (GO:0016239) | 2.65624529 |
| 119 | neuronal action potential propagation (GO:0019227) | 2.65398148 |
| 120 | cell volume homeostasis (GO:0006884) | 2.65182189 |
| 121 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.65055161 |
| 122 | hepatocyte apoptotic process (GO:0097284) | 2.65001100 |
| 123 | tricarboxylic acid cycle (GO:0006099) | 2.64496962 |
| 124 | positive regulation of Rap GTPase activity (GO:0032854) | 2.64338423 |
| 125 | cortical cytoskeleton organization (GO:0030865) | 2.64315822 |
| 126 | barbed-end actin filament capping (GO:0051016) | 2.63788168 |
| 127 | dendritic spine morphogenesis (GO:0060997) | 2.63419246 |
| 128 | prepulse inhibition (GO:0060134) | 2.63237370 |
| 129 | nuclear pore organization (GO:0006999) | 2.63202295 |
| 130 | erythrocyte maturation (GO:0043249) | 2.62771996 |
| 131 | relaxation of cardiac muscle (GO:0055119) | 2.61518068 |
| 132 | regulation of Rap GTPase activity (GO:0032317) | 2.60876973 |
| 133 | detection of calcium ion (GO:0005513) | 2.60255276 |
| 134 | heme biosynthetic process (GO:0006783) | 2.60151146 |
| 135 | vesicle transport along microtubule (GO:0047496) | 2.60065780 |
| 136 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.59486663 |
| 137 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.59205602 |
| 138 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.58803270 |
| 139 | positive regulation of potassium ion transport (GO:0043268) | 2.58552514 |
| 140 | striated muscle hypertrophy (GO:0014897) | 2.57750228 |
| 141 | cardiac muscle cell action potential (GO:0086001) | 2.57705982 |
| 142 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.57650983 |
| 143 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.57589198 |
| 144 | regulation of cation channel activity (GO:2001257) | 2.56487027 |
| 145 | fibril organization (GO:0097435) | 2.56350194 |
| 146 | negative regulation of actin filament depolymerization (GO:0030835) | 2.55428967 |
| 147 | regulation of the force of heart contraction (GO:0002026) | 2.55247209 |
| 148 | megakaryocyte development (GO:0035855) | 2.54217033 |
| 149 | positive regulation of synapse maturation (GO:0090129) | 2.53984327 |
| 150 | stress fiber assembly (GO:0043149) | 2.52628244 |
| 151 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.52627126 |
| 152 | nerve growth factor signaling pathway (GO:0038180) | 2.51763518 |
| 153 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.46841884 |
| 154 | response to lead ion (GO:0010288) | 2.43463009 |
| 155 | clathrin coat assembly (GO:0048268) | 2.42784382 |
| 156 | Rap protein signal transduction (GO:0032486) | 2.41847709 |
| 157 | regulation of early endosome to late endosome transport (GO:2000641) | 2.32838269 |
| 158 | cellular response to monoamine stimulus (GO:0071868) | 2.31093100 |
| 159 | cellular response to catecholamine stimulus (GO:0071870) | 2.31093100 |
| 160 | actin-myosin filament sliding (GO:0033275) | 2.30864328 |
| 161 | muscle filament sliding (GO:0030049) | 2.30864328 |
| 162 | striated muscle atrophy (GO:0014891) | 2.28544442 |
| 163 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.25942083 |
| 164 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.25882477 |
| 165 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.25590629 |
| 166 | regulation of anoikis (GO:2000209) | 2.25117586 |
| 167 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.25004239 |
| 168 | membrane raft organization (GO:0031579) | 2.24944193 |
| 169 | actomyosin structure organization (GO:0031032) | 2.24670719 |
| 170 | actin-mediated cell contraction (GO:0070252) | 2.24262966 |
| 171 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.23869182 |
| 172 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.23869182 |
| 173 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.23869182 |
| 174 | definitive hemopoiesis (GO:0060216) | 2.23619478 |
| 175 | response to catecholamine (GO:0071869) | 2.23285585 |
| 176 | response to monoamine (GO:0071867) | 2.23285585 |
| 177 | negative regulation of adherens junction organization (GO:1903392) | 2.23153263 |
| 178 | negative regulation of focal adhesion assembly (GO:0051895) | 2.23153263 |
| 179 | negative regulation of cell junction assembly (GO:1901889) | 2.23153263 |
| 180 | cellular response to reactive nitrogen species (GO:1902170) | 2.19509453 |
| 181 | embryonic process involved in female pregnancy (GO:0060136) | 2.19483809 |
| 182 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.18703422 |
| 183 | actin filament-based movement (GO:0030048) | 2.18370453 |
| 184 | import into cell (GO:0098657) | 2.17788799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.62728593 |
| 2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.24159978 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.09065968 |
| 4 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.92611357 |
| 5 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.58056564 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.46049718 |
| 7 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.39754255 |
| 8 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.27842883 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.27456312 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.15891948 |
| 11 | KDM2B_26808549_Chip-Seq_K562_Human | 2.12634102 |
| 12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.10314568 |
| 13 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.07748379 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.05665606 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.05665606 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.02971367 |
| 17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02250927 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00471470 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.96277691 |
| 20 | GATA1_19941826_ChIP-Seq_K562_Human | 1.90392299 |
| 21 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.90184591 |
| 22 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.84752582 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.81560942 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.77923670 |
| 25 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.76995005 |
| 26 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.74418163 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.73136770 |
| 28 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.71196785 |
| 29 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.70171418 |
| 30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.69932954 |
| 31 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.69745814 |
| 32 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.68422312 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67571740 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.67002475 |
| 35 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.66879681 |
| 36 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.65382666 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64183768 |
| 38 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.63654044 |
| 39 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.62901184 |
| 40 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.62804930 |
| 41 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.62725739 |
| 42 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.61446681 |
| 43 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60751378 |
| 44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.60623451 |
| 45 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.60559704 |
| 46 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.58983384 |
| 47 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.58537573 |
| 48 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.57652112 |
| 49 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.56946054 |
| 50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.52681154 |
| 51 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.52681154 |
| 52 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50298218 |
| 53 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.49788056 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49434607 |
| 55 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.49251930 |
| 56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48937126 |
| 57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48847637 |
| 58 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.48549006 |
| 59 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.48528016 |
| 60 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.48144426 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.47664683 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45781354 |
| 63 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.45530468 |
| 64 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.45516498 |
| 65 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45384193 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43858346 |
| 67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41373478 |
| 68 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.40726162 |
| 69 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.40577570 |
| 70 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.40387240 |
| 71 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.40387240 |
| 72 | TP53_16413492_ChIP-PET_HCT116_Human | 1.39554066 |
| 73 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.39313889 |
| 74 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38550836 |
| 75 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.37449462 |
| 76 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35595042 |
| 77 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.35211545 |
| 78 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33463669 |
| 79 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.32502570 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.32217900 |
| 81 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.30595213 |
| 82 | CJUN_26792858_Chip-Seq_BT549_Human | 1.30080129 |
| 83 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.29993771 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29218010 |
| 85 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26147679 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25740071 |
| 87 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.25207364 |
| 88 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.24664232 |
| 89 | AR_19668381_ChIP-Seq_PC3_Human | 1.23382826 |
| 90 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23324546 |
| 91 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21554757 |
| 92 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.21223848 |
| 93 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.20184128 |
| 94 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.19154082 |
| 95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.17940965 |
| 96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.17940965 |
| 97 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.17255667 |
| 98 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.17083802 |
| 99 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16050067 |
| 100 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15722856 |
| 101 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15595819 |
| 102 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14885121 |
| 103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14091780 |
| 104 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14086080 |
| 105 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.13882321 |
| 106 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.13844513 |
| 107 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.13699097 |
| 108 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13676070 |
| 109 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13341198 |
| 110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13086761 |
| 111 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.11384860 |
| 112 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10797035 |
| 113 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.10139150 |
| 114 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10120250 |
| 115 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08817095 |
| 116 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.08684678 |
| 117 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.08369821 |
| 118 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08018787 |
| 119 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07486648 |
| 120 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07364397 |
| 121 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06223698 |
| 122 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05448805 |
| 123 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05297602 |
| 124 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04975959 |
| 125 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04723925 |
| 126 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04133256 |
| 127 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04012985 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03488049 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02464973 |
| 130 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02281341 |
| 131 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01702098 |
| 132 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.01292079 |
| 133 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.00905828 |
| 134 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00412195 |
| 135 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99926940 |
| 136 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.99457220 |
| 137 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96927401 |
| 138 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96880056 |
| 139 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.96231620 |
| 140 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.96198323 |
| 141 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95386708 |
| 142 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.93814433 |
| 143 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93707506 |
| 144 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93442904 |
| 145 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93201835 |
| 146 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.91772246 |
| 147 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91692296 |
| 148 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91571738 |
| 149 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91462718 |
| 150 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90835362 |
| 151 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.90807117 |
| 152 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.90621319 |
| 153 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90489127 |
| 154 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90346453 |
| 155 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.90324499 |
| 156 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89646844 |
| 157 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89523039 |
| 158 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.87958942 |
| 159 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.86547400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.09390368 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.40421466 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.75507923 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.36012297 |
| 5 | MP0005171_absent_coat_pigmentation | 3.35568723 |
| 6 | MP0000751_myopathy | 3.29703390 |
| 7 | MP0004215_abnormal_myocardial_fiber | 3.29555250 |
| 8 | MP0003646_muscle_fatigue | 2.93898723 |
| 9 | MP0002822_catalepsy | 2.91549031 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 2.83797959 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.79389604 |
| 12 | MP0000015_abnormal_ear_pigmentation | 2.66765184 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.62459305 |
| 14 | MP0004036_abnormal_muscle_relaxation | 2.50934826 |
| 15 | MP0000749_muscle_degeneration | 2.38085679 |
| 16 | MP0003950_abnormal_plasma_membrane | 2.32920586 |
| 17 | MP0004270_analgesia | 2.32037080 |
| 18 | MP0005275_abnormal_skin_tensile | 2.30884862 |
| 19 | MP0005409_darkened_coat_color | 2.27447114 |
| 20 | MP0005330_cardiomyopathy | 2.26775653 |
| 21 | MP0001958_emphysema | 2.24183072 |
| 22 | MP0000372_irregular_coat_pigmentation | 2.14113791 |
| 23 | MP0008775_abnormal_heart_ventricle | 2.14055277 |
| 24 | MP0002063_abnormal_learning/memory/cond | 2.13167917 |
| 25 | MP0002909_abnormal_adrenal_gland | 2.08059861 |
| 26 | MP0009745_abnormal_behavioral_response | 2.07731927 |
| 27 | MP0004087_abnormal_muscle_fiber | 2.07021982 |
| 28 | MP0003137_abnormal_impulse_conducting | 2.02884211 |
| 29 | MP0008260_abnormal_autophagy | 2.02796443 |
| 30 | MP0003566_abnormal_cell_adhesion | 2.01198159 |
| 31 | MP0004130_abnormal_muscle_cell | 2.00734822 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.99352073 |
| 33 | MP0008961_abnormal_basal_metabolism | 1.99039981 |
| 34 | MP0002064_seizures | 1.99019570 |
| 35 | MP0003880_abnormal_central_pattern | 1.98448154 |
| 36 | MP0002972_abnormal_cardiac_muscle | 1.97850222 |
| 37 | MP0005083_abnormal_biliary_tract | 1.97849666 |
| 38 | MP0005408_hypopigmentation | 1.97729599 |
| 39 | MP0009046_muscle_twitch | 1.97422463 |
| 40 | MP0004085_abnormal_heartbeat | 1.95738801 |
| 41 | MP0003279_aneurysm | 1.93847522 |
| 42 | MP0005620_abnormal_muscle_contractility | 1.91098248 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.81782561 |
| 44 | MP0004484_altered_response_of | 1.81302358 |
| 45 | MP0004858_abnormal_nervous_system | 1.78183407 |
| 46 | MP0003191_abnormal_cellular_cholesterol | 1.76653531 |
| 47 | MP0003091_abnormal_cell_migration | 1.76219391 |
| 48 | MP0004147_increased_porphyrin_level | 1.69599114 |
| 49 | MP0000747_muscle_weakness | 1.66295727 |
| 50 | MP0004145_abnormal_muscle_electrophysio | 1.64019359 |
| 51 | MP0009780_abnormal_chondrocyte_physiolo | 1.63329608 |
| 52 | MP0002269_muscular_atrophy | 1.62240541 |
| 53 | MP0000371_diluted_coat_color | 1.59319776 |
| 54 | MP0001486_abnormal_startle_reflex | 1.58430758 |
| 55 | MP0008569_lethality_at_weaning | 1.56655404 |
| 56 | MP0004043_abnormal_pH_regulation | 1.55322988 |
| 57 | MP0010630_abnormal_cardiac_muscle | 1.55131473 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 1.54676681 |
| 59 | MP0005257_abnormal_intraocular_pressure | 1.54235672 |
| 60 | MP0005503_abnormal_tendon_morphology | 1.53283075 |
| 61 | MP0005451_abnormal_body_composition | 1.52803561 |
| 62 | MP0004233_abnormal_muscle_weight | 1.52756784 |
| 63 | MP0002572_abnormal_emotion/affect_behav | 1.52647061 |
| 64 | MP0002272_abnormal_nervous_system | 1.50991908 |
| 65 | MP0001544_abnormal_cardiovascular_syste | 1.44953924 |
| 66 | MP0005385_cardiovascular_system_phenoty | 1.44953924 |
| 67 | MP0002106_abnormal_muscle_physiology | 1.43039193 |
| 68 | MP0002734_abnormal_mechanical_nocicepti | 1.42622224 |
| 69 | MP0005623_abnormal_meninges_morphology | 1.42596583 |
| 70 | MP0002332_abnormal_exercise_endurance | 1.41460790 |
| 71 | MP0004510_myositis | 1.40687333 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.39240724 |
| 73 | MP0000759_abnormal_skeletal_muscle | 1.38885609 |
| 74 | MP0003303_peritoneal_inflammation | 1.36489833 |
| 75 | MP0001968_abnormal_touch/_nociception | 1.36079367 |
| 76 | MP0001849_ear_inflammation | 1.32318161 |
| 77 | MP0006138_congestive_heart_failure | 1.30120441 |
| 78 | MP0002095_abnormal_skin_pigmentation | 1.29609557 |
| 79 | MP0000750_abnormal_muscle_regeneration | 1.28252869 |
| 80 | MP0003329_amyloid_beta_deposits | 1.26380389 |
| 81 | MP0004811_abnormal_neuron_physiology | 1.24576724 |
| 82 | MP0004924_abnormal_behavior | 1.23838849 |
| 83 | MP0005386_behavior/neurological_phenoty | 1.23838849 |
| 84 | MP0004272_abnormal_basement_membrane | 1.23794783 |
| 85 | MP0004883_abnormal_blood_vessel | 1.23308372 |
| 86 | MP0005423_abnormal_somatic_nervous | 1.22875004 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 1.20566967 |
| 88 | MP0004381_abnormal_hair_follicle | 1.20359020 |
| 89 | MP0005369_muscle_phenotype | 1.18179571 |
| 90 | MP0001501_abnormal_sleep_pattern | 1.15845826 |
| 91 | MP0003633_abnormal_nervous_system | 1.13938410 |
| 92 | MP0004885_abnormal_endolymph | 1.13883202 |
| 93 | MP0005174_abnormal_tail_pigmentation | 1.13557519 |
| 94 | MP0001851_eye_inflammation | 1.12770307 |
| 95 | MP0006054_spinal_hemorrhage | 1.12226413 |
| 96 | MP0001440_abnormal_grooming_behavior | 1.11809091 |
| 97 | MP0010352_gastrointestinal_tract_polyps | 1.11745089 |
| 98 | MP0005551_abnormal_eye_electrophysiolog | 1.11547464 |
| 99 | MP0002067_abnormal_sensory_capabilities | 1.10477509 |
| 100 | MP0000013_abnormal_adipose_tissue | 1.10251055 |
| 101 | MP0002166_altered_tumor_susceptibility | 1.06891836 |
| 102 | MP0005058_abnormal_lysosome_morphology | 1.05947824 |
| 103 | MP0002127_abnormal_cardiovascular_syste | 1.04746646 |
| 104 | MP0000767_abnormal_smooth_muscle | 1.04134702 |
| 105 | MP0005075_abnormal_melanosome_morpholog | 1.03343181 |
| 106 | MP0005164_abnormal_response_to | 1.02047199 |
| 107 | MP0001970_abnormal_pain_threshold | 1.01253515 |
| 108 | MP0010368_abnormal_lymphatic_system | 1.01000688 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 1.00009610 |
| 110 | MP0001545_abnormal_hematopoietic_system | 1.00009610 |
| 111 | MP0002733_abnormal_thermal_nociception | 0.98423100 |
| 112 | MP0002009_preneoplasia | 0.95915631 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.94492554 |
| 114 | MP0003045_fibrosis | 0.94296923 |
| 115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.94273315 |
| 116 | MP0008874_decreased_physiological_sensi | 0.93626291 |
| 117 | MP0005023_abnormal_wound_healing | 0.93032989 |
| 118 | MP0002090_abnormal_vision | 0.91525394 |
| 119 | MP0010234_abnormal_vibrissa_follicle | 0.91476749 |
| 120 | MP0001915_intracranial_hemorrhage | 0.90657518 |
| 121 | MP0000733_abnormal_muscle_development | 0.89322061 |
| 122 | MP0002066_abnormal_motor_capabilities/c | 0.88825359 |
| 123 | MP0003075_altered_response_to | 0.88685925 |
| 124 | MP0003283_abnormal_digestive_organ | 0.88448951 |
| 125 | MP0002060_abnormal_skin_morphology | 0.88286536 |
| 126 | MP0002128_abnormal_blood_circulation | 0.87975602 |
| 127 | MP0000003_abnormal_adipose_tissue | 0.87467121 |
| 128 | MP0002735_abnormal_chemical_nociception | 0.87246455 |
| 129 | MP0005666_abnormal_adipose_tissue | 0.87195502 |
| 130 | MP0002998_abnormal_bone_remodeling | 0.84993930 |
| 131 | MP0000955_abnormal_spinal_cord | 0.84524000 |
| 132 | MP0001542_abnormal_bone_strength | 0.84497576 |
| 133 | MP0005165_increased_susceptibility_to | 0.84222569 |
| 134 | MP0000465_gastrointestinal_hemorrhage | 0.84211765 |
| 135 | MP0002882_abnormal_neuron_morphology | 0.83925802 |
| 136 | MP0008004_abnormal_stomach_pH | 0.82832884 |
| 137 | MP0003631_nervous_system_phenotype | 0.82215321 |
| 138 | MP0002295_abnormal_pulmonary_circulatio | 0.81272725 |
| 139 | MP0002229_neurodegeneration | 0.81046849 |
| 140 | MP0005375_adipose_tissue_phenotype | 0.80772408 |
| 141 | MP0003453_abnormal_keratinocyte_physiol | 0.80749537 |
| 142 | MP0003828_pulmonary_edema | 0.80343878 |
| 143 | MP0005535_abnormal_body_temperature | 0.80247014 |
| 144 | MP0005499_abnormal_olfactory_system | 0.80217521 |
| 145 | MP0005394_taste/olfaction_phenotype | 0.80217521 |
| 146 | MP0006035_abnormal_mitochondrial_morpho | 0.79753813 |
| 147 | MP0002234_abnormal_pharynx_morphology | 0.78411222 |
| 148 | MP0004185_abnormal_adipocyte_glucose | 0.78044982 |
| 149 | MP0002896_abnormal_bone_mineralization | 0.77933557 |
| 150 | MP0003787_abnormal_imprinting | 0.77559409 |
| 151 | MP0000266_abnormal_heart_morphology | 0.77421000 |
| 152 | MP0002736_abnormal_nociception_after | 0.76770862 |
| 153 | MP0009840_abnormal_foam_cell | 0.76540568 |
| 154 | MP0008872_abnormal_physiological_respon | 0.75692698 |
| 155 | MP0003690_abnormal_glial_cell | 0.75576158 |
| 156 | MP0002133_abnormal_respiratory_system | 0.75391751 |
| 157 | MP0005388_respiratory_system_phenotype | 0.75391751 |
| 158 | MP0000343_altered_response_to | 0.74728642 |
| 159 | MP0003879_abnormal_hair_cell | 0.73967309 |
| 160 | MP0002184_abnormal_innervation | 0.73651832 |
| 161 | MP0003300_gastrointestinal_ulcer | 0.72984085 |
| 162 | MP0005595_abnormal_vascular_smooth | 0.70486813 |
| 163 | MP0005621_abnormal_cell_physiology | 0.69169600 |
| 164 | MP0009384_cardiac_valve_regurgitation | 0.68695130 |
| 165 | MP0002971_abnormal_brown_adipose | 0.67921008 |
| 166 | MP0002108_abnormal_muscle_morphology | 0.67849026 |
| 167 | MP0000920_abnormal_myelination | 0.66504861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 4.84344591 |
| 2 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.74877402 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 3.97455717 |
| 4 | Bundle branch block (HP:0011710) | 3.93810696 |
| 5 | Myokymia (HP:0002411) | 3.89104427 |
| 6 | Atrial fibrillation (HP:0005110) | 3.82874257 |
| 7 | Exercise-induced myalgia (HP:0003738) | 3.77332136 |
| 8 | Focal motor seizures (HP:0011153) | 3.73123591 |
| 9 | Primary atrial arrhythmia (HP:0001692) | 3.66724733 |
| 10 | Aortic aneurysm (HP:0004942) | 3.66122599 |
| 11 | Arterial tortuosity (HP:0005116) | 3.63335674 |
| 12 | Difficulty running (HP:0009046) | 3.61221354 |
| 13 | Vascular tortuosity (HP:0004948) | 3.60819138 |
| 14 | Protrusio acetabuli (HP:0003179) | 3.57322407 |
| 15 | Ventricular fibrillation (HP:0001663) | 3.48208458 |
| 16 | Focal seizures (HP:0007359) | 3.46784536 |
| 17 | Supraventricular tachycardia (HP:0004755) | 3.46109818 |
| 18 | Supraventricular arrhythmia (HP:0005115) | 3.40425415 |
| 19 | Osteolytic defects of the hand bones (HP:0009699) | 3.35969814 |
| 20 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.35969814 |
| 21 | Ventricular tachycardia (HP:0004756) | 3.33264137 |
| 22 | Visual hallucinations (HP:0002367) | 3.31945875 |
| 23 | Abnormality of the lower motor neuron (HP:0002366) | 3.27332402 |
| 24 | Hypochromic microcytic anemia (HP:0004840) | 3.20297785 |
| 25 | Resting tremor (HP:0002322) | 3.19574118 |
| 26 | Dysmetric saccades (HP:0000641) | 3.19480184 |
| 27 | Prolonged QT interval (HP:0001657) | 3.18568785 |
| 28 | Premature rupture of membranes (HP:0001788) | 3.17492102 |
| 29 | Hyporeflexia of lower limbs (HP:0002600) | 3.13607202 |
| 30 | Calf muscle hypertrophy (HP:0008981) | 3.12686450 |
| 31 | Syncope (HP:0001279) | 3.10474248 |
| 32 | Polycythemia (HP:0001901) | 3.06532507 |
| 33 | Microcytic anemia (HP:0001935) | 2.95988112 |
| 34 | Aortic dissection (HP:0002647) | 2.95479395 |
| 35 | Abnormality of the calf musculature (HP:0001430) | 2.94707745 |
| 36 | Abnormal gallbladder physiology (HP:0012438) | 2.89855216 |
| 37 | Cholecystitis (HP:0001082) | 2.89855216 |
| 38 | Subaortic stenosis (HP:0001682) | 2.87444181 |
| 39 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.87444181 |
| 40 | Heart block (HP:0012722) | 2.85329039 |
| 41 | Ocular albinism (HP:0001107) | 2.85006187 |
| 42 | Depression (HP:0000716) | 2.84848590 |
| 43 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.84040567 |
| 44 | Poikilocytosis (HP:0004447) | 2.83902696 |
| 45 | Myoglobinuria (HP:0002913) | 2.83121592 |
| 46 | Muscle fiber splitting (HP:0003555) | 2.82588525 |
| 47 | Ventricular arrhythmia (HP:0004308) | 2.82050217 |
| 48 | Cerebral aneurysm (HP:0004944) | 2.80824538 |
| 49 | Atrioventricular block (HP:0001678) | 2.80366257 |
| 50 | Increased connective tissue (HP:0009025) | 2.75409995 |
| 51 | Central scotoma (HP:0000603) | 2.75297766 |
| 52 | Insomnia (HP:0100785) | 2.74026099 |
| 53 | Spondylolisthesis (HP:0003302) | 2.71968407 |
| 54 | Abnormal atrioventricular conduction (HP:0005150) | 2.71701804 |
| 55 | Abnormal EKG (HP:0003115) | 2.71258705 |
| 56 | Lower limb amyotrophy (HP:0007210) | 2.69953715 |
| 57 | Action tremor (HP:0002345) | 2.67691072 |
| 58 | Impaired social interactions (HP:0000735) | 2.65637298 |
| 59 | Abnormal social behavior (HP:0012433) | 2.65637298 |
| 60 | Hypoplasia of the iris (HP:0007676) | 2.61601467 |
| 61 | EMG: myopathic abnormalities (HP:0003458) | 2.61327399 |
| 62 | Dysdiadochokinesis (HP:0002075) | 2.58873266 |
| 63 | Febrile seizures (HP:0002373) | 2.54932037 |
| 64 | Postural instability (HP:0002172) | 2.54695109 |
| 65 | Poor eye contact (HP:0000817) | 2.49950713 |
| 66 | Epileptic encephalopathy (HP:0200134) | 2.49446272 |
| 67 | Increased variability in muscle fiber diameter (HP:0003557) | 2.46690816 |
| 68 | Blue irides (HP:0000635) | 2.45857063 |
| 69 | Myotonia (HP:0002486) | 2.45814941 |
| 70 | Generalized tonic-clonic seizures (HP:0002069) | 2.43986742 |
| 71 | Wormian bones (HP:0002645) | 2.43075845 |
| 72 | Cholelithiasis (HP:0001081) | 2.41906578 |
| 73 | Reticulocytosis (HP:0001923) | 2.40137030 |
| 74 | Urinary urgency (HP:0000012) | 2.35658769 |
| 75 | Iris hypopigmentation (HP:0007730) | 2.31619876 |
| 76 | Scotoma (HP:0000575) | 2.31205347 |
| 77 | Cerebral inclusion bodies (HP:0100314) | 2.28850383 |
| 78 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.28443815 |
| 79 | Type 1 muscle fiber predominance (HP:0003803) | 2.26958685 |
| 80 | Acanthocytosis (HP:0001927) | 2.26709952 |
| 81 | Atonic seizures (HP:0010819) | 2.26041733 |
| 82 | Absence seizures (HP:0002121) | 2.24670467 |
| 83 | Upper limb amyotrophy (HP:0009129) | 2.24292377 |
| 84 | Distal upper limb amyotrophy (HP:0007149) | 2.24292377 |
| 85 | Distal lower limb muscle weakness (HP:0009053) | 2.23531322 |
| 86 | Right ventricular cardiomyopathy (HP:0011663) | 2.22772939 |
| 87 | Rapidly progressive (HP:0003678) | 2.22563302 |
| 88 | Papillary thyroid carcinoma (HP:0002895) | 2.22129850 |
| 89 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.21690189 |
| 90 | Anxiety (HP:0000739) | 2.20362229 |
| 91 | Aneurysm (HP:0002617) | 2.19405067 |
| 92 | Overgrowth (HP:0001548) | 2.19204772 |
| 93 | Gingival bleeding (HP:0000225) | 2.19067619 |
| 94 | Dialeptic seizures (HP:0011146) | 2.19026202 |
| 95 | Distal lower limb amyotrophy (HP:0008944) | 2.18171807 |
| 96 | Lipoatrophy (HP:0100578) | 2.17984328 |
| 97 | Difficulty climbing stairs (HP:0003551) | 2.17646121 |
| 98 | Mitral stenosis (HP:0001718) | 2.15533510 |
| 99 | Hamartoma of the eye (HP:0010568) | 2.14386183 |
| 100 | Papilledema (HP:0001085) | 2.13843190 |
| 101 | Dilatation of the ascending aorta (HP:0005111) | 2.10997012 |
| 102 | White forelock (HP:0002211) | 2.10285390 |
| 103 | Macroorchidism (HP:0000053) | 2.08755410 |
| 104 | Achilles tendon contracture (HP:0001771) | 2.08721792 |
| 105 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.06890072 |
| 106 | Prolonged bleeding time (HP:0003010) | 2.06293389 |
| 107 | Mitral valve prolapse (HP:0001634) | 2.05604729 |
| 108 | Asymmetric septal hypertrophy (HP:0001670) | 2.05420157 |
| 109 | EMG: neuropathic changes (HP:0003445) | 2.03250588 |
| 110 | Ankle clonus (HP:0011448) | 2.03214186 |
| 111 | Lymphangioma (HP:0100764) | 2.01395122 |
| 112 | Abnormal gallbladder morphology (HP:0012437) | 2.00514300 |
| 113 | Spontaneous hematomas (HP:0007420) | 1.99726114 |
| 114 | Increased mean platelet volume (HP:0011877) | 1.99342274 |
| 115 | Hemiplegia (HP:0002301) | 1.97978213 |
| 116 | Supranuclear gaze palsy (HP:0000605) | 1.97450272 |
| 117 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.96987549 |
| 118 | Neoplasm of the heart (HP:0100544) | 1.96549214 |
| 119 | Dysmetria (HP:0001310) | 1.95592865 |
| 120 | Peritonitis (HP:0002586) | 1.95246973 |
| 121 | Termporal pattern (HP:0011008) | 1.93931296 |
| 122 | Insidious onset (HP:0003587) | 1.93931296 |
| 123 | Striae distensae (HP:0001065) | 1.93198848 |
| 124 | Diaphragmatic weakness (HP:0009113) | 1.92834072 |
| 125 | Dilated cardiomyopathy (HP:0001644) | 1.92624287 |
| 126 | Decreased motor nerve conduction velocity (HP:0003431) | 1.91036164 |
| 127 | Status epilepticus (HP:0002133) | 1.89945008 |
| 128 | Annular pancreas (HP:0001734) | 1.89675623 |
| 129 | Mucopolysacchariduria (HP:0008155) | 1.89154263 |
| 130 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89154263 |
| 131 | Abnormality of the Achilles tendon (HP:0005109) | 1.87857691 |
| 132 | Truncal ataxia (HP:0002078) | 1.87702202 |
| 133 | Intention tremor (HP:0002080) | 1.86871366 |
| 134 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.86073923 |
| 135 | Testicular atrophy (HP:0000029) | 1.85843856 |
| 136 | Neonatal hypoglycemia (HP:0001998) | 1.85221135 |
| 137 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.83160692 |
| 138 | Abnormal platelet volume (HP:0011876) | 1.82240769 |
| 139 | Subacute progressive viral hepatitis (HP:0006572) | 1.81019346 |
| 140 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.80684236 |
| 141 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.80684236 |
| 142 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.80684236 |
| 143 | Soft skin (HP:0000977) | 1.80453778 |
| 144 | Foot dorsiflexor weakness (HP:0009027) | 1.79161680 |
| 145 | Fragile skin (HP:0001030) | 1.78065022 |
| 146 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.77299916 |
| 147 | Horizontal nystagmus (HP:0000666) | 1.77193528 |
| 148 | Pointed chin (HP:0000307) | 1.77189713 |
| 149 | Frequent falls (HP:0002359) | 1.77037859 |
| 150 | Dysostosis multiplex (HP:0000943) | 1.76210254 |
| 151 | Hypopigmentation of the fundus (HP:0007894) | 1.76166188 |
| 152 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.75734372 |
| 153 | Progressive cerebellar ataxia (HP:0002073) | 1.75731954 |
| 154 | Patchy hypopigmentation of hair (HP:0011365) | 1.75417323 |
| 155 | Testicular neoplasm (HP:0010788) | 1.73336989 |
| 156 | Slow saccadic eye movements (HP:0000514) | 1.73273253 |
| 157 | Muscle stiffness (HP:0003552) | 1.72540800 |
| 158 | Absent frontal sinuses (HP:0002688) | 1.71979471 |
| 159 | Paralysis (HP:0003470) | 1.71948015 |
| 160 | Obstructive sleep apnea (HP:0002870) | 1.70397376 |
| 161 | Amblyopia (HP:0000646) | 1.69840625 |
| 162 | Bradykinesia (HP:0002067) | 1.69819449 |
| 163 | Hypercortisolism (HP:0001578) | 1.69279816 |
| 164 | Orthostatic hypotension (HP:0001278) | 1.68234863 |
| 165 | Epistaxis (HP:0000421) | 1.65885313 |
| 166 | Abnormality of the gallbladder (HP:0005264) | 1.65701227 |
| 167 | Toxemia of pregnancy (HP:0100603) | 1.65266559 |
| 168 | Abnormality of the foot musculature (HP:0001436) | 1.65075596 |
| 169 | Mild short stature (HP:0003502) | 1.62923458 |
| 170 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.62470960 |
| 171 | Albinism (HP:0001022) | 1.61955595 |
| 172 | Vertebral compression fractures (HP:0002953) | 1.61931042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.24719195 |
| 2 | EIF2AK1 | 3.03945439 |
| 3 | MAP3K9 | 2.72538081 |
| 4 | NTRK3 | 2.63207674 |
| 5 | TRIB3 | 2.56672856 |
| 6 | MUSK | 2.46576902 |
| 7 | TTN | 2.27871597 |
| 8 | CDK12 | 2.19945851 |
| 9 | MAP3K3 | 2.15584191 |
| 10 | LMTK2 | 2.14857102 |
| 11 | PRKD3 | 2.14381876 |
| 12 | MAP2K3 | 2.14027059 |
| 13 | KSR2 | 2.01265186 |
| 14 | PKN2 | 2.00998425 |
| 15 | PHKG2 | 2.00420956 |
| 16 | PHKG1 | 2.00420956 |
| 17 | NEK1 | 1.98233592 |
| 18 | PAK6 | 1.95262194 |
| 19 | GRK5 | 1.92721099 |
| 20 | DAPK2 | 1.88807513 |
| 21 | TRPM7 | 1.85474243 |
| 22 | RIPK1 | 1.82778389 |
| 23 | NEK9 | 1.79826683 |
| 24 | CAMKK1 | 1.78971499 |
| 25 | STK38 | 1.78265385 |
| 26 | MAP3K4 | 1.76603930 |
| 27 | DMPK | 1.74527454 |
| 28 | WNK1 | 1.72895503 |
| 29 | TYRO3 | 1.57930902 |
| 30 | TAOK1 | 1.56389783 |
| 31 | STK4 | 1.56201961 |
| 32 | NTRK1 | 1.52447462 |
| 33 | MINK1 | 1.50553571 |
| 34 | PINK1 | 1.49538927 |
| 35 | MAP2K4 | 1.44715517 |
| 36 | MAP3K7 | 1.35135161 |
| 37 | PDK4 | 1.31237011 |
| 38 | PDK3 | 1.31237011 |
| 39 | PRKCH | 1.31179835 |
| 40 | IRAK3 | 1.24518223 |
| 41 | SGK3 | 1.19886954 |
| 42 | JAK1 | 1.17956552 |
| 43 | MARK1 | 1.17261858 |
| 44 | PDGFRA | 1.15856053 |
| 45 | MAP3K6 | 1.15276926 |
| 46 | OBSCN | 1.15258934 |
| 47 | ZAP70 | 1.13381258 |
| 48 | PAK3 | 1.13338923 |
| 49 | DDR2 | 1.13084855 |
| 50 | ALK | 1.12698425 |
| 51 | TAOK2 | 1.12062207 |
| 52 | MARK3 | 1.11917774 |
| 53 | SIK2 | 1.08647601 |
| 54 | CDK5 | 1.05557723 |
| 55 | RET | 1.05456060 |
| 56 | MAP3K5 | 1.05350414 |
| 57 | NTRK2 | 1.00828273 |
| 58 | CAMK4 | 1.00654343 |
| 59 | PIK3CG | 0.99471393 |
| 60 | CAMK1G | 0.99064386 |
| 61 | GRK6 | 0.98826986 |
| 62 | AKT3 | 0.98396007 |
| 63 | CDC42BPA | 0.98335813 |
| 64 | KSR1 | 0.94461617 |
| 65 | RPS6KA2 | 0.93025444 |
| 66 | PDK1 | 0.92875239 |
| 67 | SGK494 | 0.89464639 |
| 68 | SGK223 | 0.89464639 |
| 69 | MARK2 | 0.89042474 |
| 70 | STK24 | 0.87191789 |
| 71 | PRKAA2 | 0.86559552 |
| 72 | MAP3K2 | 0.83865343 |
| 73 | MELK | 0.83547278 |
| 74 | PRKAA1 | 0.83252878 |
| 75 | STK11 | 0.83046902 |
| 76 | RIPK4 | 0.82660912 |
| 77 | CAMK1 | 0.82388459 |
| 78 | PLK2 | 0.81969789 |
| 79 | SGK2 | 0.81300215 |
| 80 | PDPK1 | 0.81008262 |
| 81 | PRKD1 | 0.80699466 |
| 82 | MET | 0.80071750 |
| 83 | SGK1 | 0.79721165 |
| 84 | MAPK12 | 0.79629842 |
| 85 | CAMK1D | 0.78224057 |
| 86 | SCYL2 | 0.73651132 |
| 87 | FGFR4 | 0.72352507 |
| 88 | MTOR | 0.72064689 |
| 89 | PTK2B | 0.70862975 |
| 90 | IKBKE | 0.69255744 |
| 91 | CDK6 | 0.68941069 |
| 92 | WNK4 | 0.67803098 |
| 93 | PIM1 | 0.67177604 |
| 94 | CAMKK2 | 0.64089856 |
| 95 | CLK1 | 0.63924450 |
| 96 | RPS6KA3 | 0.63554459 |
| 97 | GRK7 | 0.63177982 |
| 98 | MAP3K10 | 0.62779046 |
| 99 | STK3 | 0.61977365 |
| 100 | LATS1 | 0.61904462 |
| 101 | BMX | 0.61897317 |
| 102 | PTK2 | 0.61324097 |
| 103 | UHMK1 | 0.61265829 |
| 104 | JAK2 | 0.60991533 |
| 105 | BLK | 0.60620096 |
| 106 | EPHB1 | 0.60394469 |
| 107 | TGFBR2 | 0.60069177 |
| 108 | FGR | 0.60004452 |
| 109 | SYK | 0.59306840 |
| 110 | MAPK7 | 0.59230255 |
| 111 | ERN1 | 0.58465779 |
| 112 | DAPK1 | 0.58222231 |
| 113 | TYK2 | 0.57623154 |
| 114 | PDK2 | 0.56940649 |
| 115 | CCNB1 | 0.55801540 |
| 116 | LATS2 | 0.55127895 |
| 117 | PAK2 | 0.54277544 |
| 118 | NLK | 0.53140302 |
| 119 | MAPK11 | 0.51283691 |
| 120 | FES | 0.50989335 |
| 121 | MAP3K13 | 0.50987304 |
| 122 | CDK15 | 0.48594357 |
| 123 | FGFR3 | 0.48411321 |
| 124 | ROCK2 | 0.48041073 |
| 125 | ROCK1 | 0.47867348 |
| 126 | CAMK2A | 0.47340194 |
| 127 | SIK1 | 0.46983205 |
| 128 | PRKCG | 0.46852364 |
| 129 | PRKD2 | 0.46464075 |
| 130 | DAPK3 | 0.45801958 |
| 131 | PRKACG | 0.45688887 |
| 132 | MAP3K1 | 0.45345574 |
| 133 | ICK | 0.45298636 |
| 134 | MAPK10 | 0.44422560 |
| 135 | RAF1 | 0.44288564 |
| 136 | CDK18 | 0.43020845 |
| 137 | PDGFRB | 0.42547732 |
| 138 | CAMK2D | 0.41644823 |
| 139 | PIK3CA | 0.40877230 |
| 140 | MAP2K1 | 0.40651730 |
| 141 | PRPF4B | 0.40144187 |
| 142 | CDK14 | 0.39733983 |
| 143 | HIPK2 | 0.39668051 |
| 144 | MYLK | 0.38494936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 2.20001514 |
| 2 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.15630759 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.08851462 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.08153384 |
| 5 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.07006207 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 1.92934527 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.92663147 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 1.91346368 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.81866315 |
| 10 | * GABAergic synapse_Homo sapiens_hsa04727 | 1.76584969 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.75004161 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 1.72922393 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.71745089 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.70525520 |
| 15 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.69898577 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67507551 |
| 17 | Nicotine addiction_Homo sapiens_hsa05033 | 1.64305739 |
| 18 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.63357956 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 1.62746837 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60813482 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56905417 |
| 22 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.56114995 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.55421569 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.54368425 |
| 25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.51576723 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.49463120 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.48874912 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.48706332 |
| 29 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.47833027 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.47741434 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.47563417 |
| 32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.45912506 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.44719028 |
| 34 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.44586878 |
| 35 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.42364894 |
| 36 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.38474887 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31355055 |
| 38 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.30750722 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.30122242 |
| 40 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29946164 |
| 41 | Adherens junction_Homo sapiens_hsa04520 | 1.29265129 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22362091 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.21544486 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.19775830 |
| 45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.19771021 |
| 46 | Prostate cancer_Homo sapiens_hsa05215 | 1.19520472 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.19501757 |
| 48 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.17525430 |
| 49 | Circadian rhythm_Homo sapiens_hsa04710 | 1.15925891 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 1.12665129 |
| 51 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.12135328 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 1.10845496 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10727444 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.10630563 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10309225 |
| 56 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.10297267 |
| 57 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.08556805 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.08455651 |
| 59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06952146 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05806400 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02653273 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.00574139 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99463842 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98347167 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97695670 |
| 66 | Taste transduction_Homo sapiens_hsa04742 | 0.97131437 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96172098 |
| 68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93075547 |
| 69 | Cocaine addiction_Homo sapiens_hsa05030 | 0.91948337 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 0.91900497 |
| 71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90962137 |
| 72 | Melanoma_Homo sapiens_hsa05218 | 0.90300186 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90169402 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89491599 |
| 75 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87959788 |
| 76 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.87739515 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.87482128 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86063647 |
| 79 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84463920 |
| 80 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81874874 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81713316 |
| 82 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.81161812 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80574098 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.80149197 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.80020961 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.77275346 |
| 87 | Hepatitis B_Homo sapiens_hsa05161 | 0.76263644 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75976738 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75042597 |
| 90 | Phototransduction_Homo sapiens_hsa04744 | 0.74879248 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74419933 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | 0.73916322 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.73810309 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73362587 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.72339450 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71096656 |
| 97 | Alcoholism_Homo sapiens_hsa05034 | 0.70607320 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69074863 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68480868 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68271728 |
| 101 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67864403 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67018058 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.66721073 |
| 104 | Colorectal cancer_Homo sapiens_hsa05210 | 0.66126506 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65392275 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65017455 |
| 107 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64730449 |
| 108 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64151844 |
| 109 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64115053 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63740524 |
| 111 | ABC transporters_Homo sapiens_hsa02010 | 0.63583823 |
| 112 | Melanogenesis_Homo sapiens_hsa04916 | 0.63547022 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.62737580 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61903900 |
| 115 | Focal adhesion_Homo sapiens_hsa04510 | 0.61018705 |
| 116 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60089721 |
| 117 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.59451016 |
| 118 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58622759 |
| 119 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58471276 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.56525541 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56234873 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55645690 |
| 123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54741216 |
| 124 | Measles_Homo sapiens_hsa05162 | 0.54366653 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.54042199 |
| 126 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.53830955 |
| 127 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53247505 |
| 128 | Pathways in cancer_Homo sapiens_hsa05200 | 0.52928134 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.52619049 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.51921535 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.51458831 |
| 132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51241185 |
| 133 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50877799 |
| 134 | Axon guidance_Homo sapiens_hsa04360 | 0.50285747 |
| 135 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49615644 |
| 136 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.48166184 |
| 137 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47975513 |
| 138 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47239941 |
| 139 | Tight junction_Homo sapiens_hsa04530 | 0.47214467 |
| 140 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.46448309 |
| 141 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.45320839 |
| 142 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.45219792 |
| 143 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.43623758 |
| 144 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43411702 |

